Bristol-Myers Squibb Aktie

65.83 CHF -0.25CHF -0.37%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 99.90
Vanguard Group, Inc. (Subfiler) 8.11
The Vanguard Group, Inc. 7.90
Wellington Management Co. LLP 6.73
State Street Corp. 4.21
Wellington Management Co. LLP 3.56
Dodge & Cox 3.10
Vanguard Health Care Fund 3.08
Vanguard Total Stock Market Index Fund 2.82
BlackRock Institutional Trust Co. NA 2.56
Fidelity Management & Research Co. LLC 2.48
BlackRock Fund Advisors 2.18
Renaissance Technologies LLC 2.01
Vanguard 500 Index Fund 1.99
Dodge & Cox Funds - Stock Fund 1.87

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 25'000 25'000 23'700 23'300 0
Umsatz pro Mitarbeiter in Mio. EUR 0.66 0.78 0.88 0.97 0.00

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 10'415 13'704 14'854 17'160 0
Summe Anlagevermögen 20'955 22'885 19'703 21'380 0
Summe Aktiva 31'748 33'707 33'551 34'986 0

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 6'689 6'708 7'962 7'349 46'733
Summe Fremdkapital 17'324 17'360 21'704 20'859 43'387
Summe Eigenkapital 14'424 16'347 11'847 14'127 0
Summe Passiva 31'748 33'707 33'551 34'986 0

Adresse

430 East 29th Street, 10154 New York
Telefon +1 (212) 546-4000
Internet http://www.bms.com

Management

Adam Dubow
Senior VP, Chief Compliance & Ethics Officer
Alan J. Lacy
Independent Director
Ann Powell Judge
Chief Human Resources Officer & Senior VP
Christopher S. Boerner
Chief Commercial Officer & Executive VP
David Feltquate
Head-Early Clinical Development
David V. Elkins
Chief Financial Officer & Executive Vice President
Dinesh C Paliwal
Independent Director
Fouad Namouni
Head-Oncology Development
Gerald L. Storch
Independent Director
Giovanni Caforio
Chairman & Chief Executive Officer
Jenny Gizzi
Head-Strategy, Operations & Business Insights
Johanna Mercier
President-US Commercial
John E. Elicker
Head-Investor Relations
John E. Elicker
EVP-Corporate Affairs & Investor Relations
Julia A. Haller
Director
Karen H. Vousden
Independent Director
Karen Murphy Santiago
Senior Vice President & Corporate Controller
Katherine Reynolds Kelly
Secretary & Vice President
Laura Hortas
Head-Corporate & Employee Communications
Lawrence Gan
Director
Louis S. Schmukler
President-Global Product Development & Supply
Matthew W. Emmens
Independent Director
Michael Grobstein
Independent Director
Michael W. Bonney
Director
Paul R. Biondi
Senior VP, Head Strategy & Business Development
Paul von Autenried
Chief Information Officer & Senior Vice President
Peter J. Arduini
Independent Director
Phyllis R. Yale
Director
Robert J. Bertolini
Independent Director
Rupert J. Vessey
President-Research & Early Development
Sabine Maier
Executive Director & Clinical Team Lead
Samit Hirawat
Chief Medical Officer-Global Drug Development
Sandra Leung
Executive Vice President & General Counsel
Saurabh Saha
Senior Vice P & Head-Translational Medicine
Theodore Rapp Samuels
Independent Director
Vicki L. Sato
Lead Independent Director

Eintrag hinzufügen

;